These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17890092)

  • 21. Primary CNS lymphoma associated with streptococcal abscess: an autopsy case.
    Kano M; Watanabe M; Maeda M
    Brain Tumor Pathol; 1999; 16(2):92-7. PubMed ID: 10746967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory demyelinating brain lesions heralding primary CNS lymphoma.
    Husseini L; Saleh A; Reifenberger G; Hartung HP; Kieseier BC
    Can J Neurol Sci; 2012 Jan; 39(1):6-10. PubMed ID: 22384490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary central nervous system lymphoma presenting as an acute massive intracerebral hemorrhage: case report with immunohistochemical study.
    Kim IY; Jung S; Jung TY; Kang SS; Choi C
    Surg Neurol; 2008 Sep; 70(3):308-11. PubMed ID: 18207523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary CNS Lymphoma vs. Tumefactive Multiple Sclerosis: A Diagnostic Challenge.
    Naeem SB; Niazi F; Baig A; Sadiq H; Sattar M
    J Coll Physicians Surg Pak; 2018 Jan; 28(1):66-68. PubMed ID: 29290197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudotumoral demyelinating lesions: diagnostic approach and long-term outcome.
    Hardy TA
    Curr Opin Neurol; 2019 Jun; 32(3):467-474. PubMed ID: 30844860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple primary central nervous system lymphoma in the elderly: A case report.
    Chen G; Xu M; Wang X; Gao Y; He C; Chang M; Zhang J
    Medicine (Baltimore); 2019 Aug; 98(35):e16841. PubMed ID: 31464910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraneoplastic tumefactive demyelination with underlying combined germ cell cancer.
    Broadfoot JR; Archer HA; Coulthard E; Appelman AP; Sutak J; Braybrooke JP; Love S
    Pract Neurol; 2015 Dec; 15(6):451-5. PubMed ID: 26088612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central nervous system lymphoma presenting with ataxic hemiparesis: a case report.
    Arai H; Tomioka K; Nakazato Y
    Clin Neurol Neurosurg; 1993 Jun; 95(2):147-9. PubMed ID: 8344014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A case of malignant lymphoma of the cranial vault].
    Kanai M; Kawano K; Murakami T; Saitou M; Kikumoto N
    No Shinkei Geka; 2003 Apr; 31(4):419-24. PubMed ID: 12704823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary intracerebral non-Hodgkin's lymphoma--a clinicopathologic study].
    Bergmann M; Kuchelmeister K; Winkelmüller W; Braun W; Behrens E; von Wild K
    Zentralbl Neurochir; 1993; 54(3):110-8. PubMed ID: 8237163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinguishing primary central nervous system lymphoma from other central nervous system diseases: a neurosurgical perspective on diagnostic dilemmas and approaches.
    Hunt MA; Jahnke K; Murillo TP; Neuwelt EA
    Neurosurg Focus; 2006 Nov; 21(5):E3. PubMed ID: 17134119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case report of unusual leukoencephalopathy preceding primary CNS lymphoma.
    Brecher K; Hochberg FH; Louis DN; de la Monte S; Riskind P
    J Neurol Neurosurg Psychiatry; 1998 Dec; 65(6):917-20. PubMed ID: 9854972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Hodgkin's lymphoma presenting as multiple bone lesions and hypercalcemia.
    Takasaki H; Kanamori H; Takabayashi M; Yamaji S; Koharazawa H; Taguchi J; Fujimaki K; Ishigatsubo Y
    Am J Hematol; 2006 Jun; 81(6):439-42. PubMed ID: 16680736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroinflammation Preceding and Accompanying Primary Central Nervous System Lymphoma: Case Study and Literature Review.
    Lu JQ; O'Kelly C; Girgis S; Emery D; Power C; Blevins G
    World Neurosurg; 2016 Apr; 88():692.e1-692.e8. PubMed ID: 26724610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
    Karantanis D; O'Neill BP; Subramaniam RM; Peller PJ; Witte RJ; Mullan BP; Wiseman GA
    Clin Nucl Med; 2007 Apr; 32(4):271-4. PubMed ID: 17413571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
    Mabray MC; Cohen BA; Villanueva-Meyer JE; Valles FE; Barajas RF; Rubenstein JL; Cha S
    AJR Am J Roentgenol; 2015 Nov; 205(5):1075-85. PubMed ID: 26496556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demyelination after primary central nervous system lymphoma; reversed ‘sentinel’.
    Barun B; Kinda S; Aurer I; Žarković K; Adamec I; Habek M
    Can J Neurol Sci; 2012 Nov; 39(6):843-4. PubMed ID: 23230617
    [No Abstract]   [Full Text] [Related]  

  • 38. Fluorescein sodium-guided biopsy or resection in primary central nervous system lymphomas with contrast-enhancing lesion in MRI.
    Lin FH; Zhang XH; Zhang J; He ZQ; Duan H; Ke C; Sai K; Jiang XB; Al-Nahari F; Xi SY; Mou YG
    J Neurooncol; 2018 Sep; 139(3):757-765. PubMed ID: 30117022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumefactive demyelinating lesion: experience with two unusual patients.
    Sinha MK; Garg RK; Bhatt ML; Chandra A
    J Postgrad Med; 2010; 56(2):146-9. PubMed ID: 20622396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different imaging patterns of PCNSL and IVL: a case report.
    Jeon SH; Kang MK; Lee SJ; Shin BS; Kang HG
    BMC Neurol; 2019 Dec; 19(1):311. PubMed ID: 31795989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.